MediciNova, Inc. (MNOV)
NASDAQ: MNOV · Real-Time Price · USD
1.810
+0.070 (4.02%)
Sep 11, 2026, 4:00 PM EDT - Market closed
MediciNova Employees
MediciNova had 6 employees as of December 31, 2025. The number of employees decreased by 7 or -53.85% compared to the previous year.
Employees
6
Change (1Y)
-7
Growth (1Y)
-53.85%
Revenue / Employee
$153,414
Profits / Employee
-$1,792,175
Market Cap
89.09M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 6 | -7 | -53.85% |
| Dec 31, 2024 | 13 | 0 | - |
| Dec 31, 2023 | 13 | 0 | - |
| Dec 31, 2022 | 13 | 2 | 18.18% |
| Dec 31, 2021 | 11 | 2 | 22.22% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Fortress Biotech | 78 |
| Acrivon Therapeutics | 76 |
| Verrica Pharmaceuticals | 76 |
| ImmuCell | 73 |
| Cardiff Oncology | 31 |
| Cognition Therapeutics | 14 |
| Nutriband | 13 |
| Atara Biotherapeutics | 10 |
MNOV News
- 1 day ago - MediciNova Transcript: H.C. Wainwright 28th Annual Global Investment Conference - Transcripts
- 4 days ago - MediciNova to Participate in Two Investor Conferences in September - GlobeNewsWire
- 4 weeks ago - MediciNova Quarterly report: Q2 2026 - Filings
- 1 month ago - MediciNova Announces Patient Enrollment Milestone Achieved in SEANOBI Study Expanded-Access-Program Evaluating MN‑166 (ibudilast) in ALS patients - GlobeNewsWire
- 2 months ago - MediciNova CEO Provides Shareholder Update - GlobeNewsWire
- 3 months ago - MediciNova Receives Notice of Allowance for New Patent Covering Use of MN-166 in Combination with Anti-PD-1 Immune Checkpoint Inhibitor for Glioblastoma Treatment - GlobeNewsWire
- 3 months ago - MediciNova Announces Completion of Last Patient Last Visit in the MN-001-NATG-202 Clinical Trial of MN-001 (Tipelukast) - GlobeNewsWire
- 3 months ago - MediciNova Slides: Corporate presentation - Filings